Search Results 191-200 of 18583 for Appendix

1. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Recurrent cancer, Liver metastasis, Duodenal cancer, Bile duct injury, Bile duct cyst ...

2. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Recurrent cancer, Liver metastasis, Duodenal cancer, Bile duct injury, Bile duct cyst ...

3. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Stage 4 colorectal cancer, Recurrent cancer, Duodenal cancer, Bile duct injury, Bile duct ...

4. Barium sulfate (oral route) - Side effects & uses - Mayo Clinic

   Asthma, hay fever, or other allergies, history of—May increase risk for allergic reaction to occur again. Appendicitis (inflammation of the appendix) or ...

5. Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis - Mayo Clinic

   Subjects with an MMT-8 score ≤ 66 (see Appendix B) must also have at least 2 other core set measures meeting the criteria listed below. Subjects with an ...

6. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

   An indication for treatment per IWCLL 2018 criteria (Appendix 2) and radiographically measurable disease (at least 1 lesion > 1.5cm in diameter). Adequate ...

7. A Study To Evaluate Efficacy, Safety And Tolerability Of CK-2127107 In Patients With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   Use of a medication that is an OCT1/OCT2 substrate within 7 days (see Appendix B). Participating Mayo Clinic locations. Study statuses change often. Please ...

8. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

   See Appendix Section 10.6 Immunosuppresant drugs, (Table 10 5 Immunosuppressant drug exclusions) 18. Known active hepatitis B or C infection, or positive ...

9. SBRT for Oligometastatic Castration-Refractory Prostate Cancer - Mayo Clinic

   Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≤ 2 (Appendix I). Life expectancy > 6 months. Exclusion Criteria: Emergent cord ...

10. A Study Evaluating A Decision Support Tool For Patients And Caregivers Offered A Heart Assist Device For End Stage Heart Failure - Mayo Clinic

    ... Appendix) conducted postal surveys in England, The Netherlands and Sweden which indicate a striking similarity in the relative valuations attached to 14 ...